I chose this article on 23andMe and chose it as this week’s DNA Saturdays post – 23andMe, moving beyond consumer DNA tests, is building a clinical trial recruitment business: https://www.statnews.com/2019/09/26/23andme-clinical-trial-recruitment/.
SAN FRANCISCO — Consumer genetics giant 23andMe announced Thursday that it would move deeper into the business of clinical trial recruitment, partnering with a fast-growing startup to help match its customers with nearby study sites based on their diseases, demographics, and DNA.
But the new partnership with TrialSpark, which offers a tech-powered alternative to traditional contract research organizations, may help 23andMe address one of the biggest challenges in clinical trial recruitment: geography. The idea is that patients who want to enroll in a clinical trial centered out of, say, Memorial Sloan Kettering Cancer Center, won’t have to fly to New York and can instead participate by visiting their local doctor’s office.
Of 23andMe’s 10 million customers, it considers about 8 million of them to be engaged research participants, meaning that they’ve opted to participate in research and regularly log into their account. More than 75% of 23andMe’s customers complete at least one of the surveys that the company hosts on its site asking them about any medical conditions they may have, among other things.
I am not familiar with TrialSpark: https://www.trialspark.com/.
Other DNA Saturdays posts: https://upsdownsfamilyhistory.wordpress.com/tag/DNA-Saturdays/